Company intelligence / Profile preview

Cenefom

Ownership: Private
Development stage: Commercial

Overview

Cenefom’s proprietary air-pore PVA foam technology is used in medical devices for wound care, surgical cleaning, hemostasis, and other clinical applications. The products are CE and FDA certified and distributed globally. No clinical trial results apply as these are medical devices/materials rather than therapeutics.

Therapeutic areas: HematologyOtherDermatologyOphthalmologyNephrology
Modalities: DevicePolymer-based material (PVA foam)Drug delivery system (via PVA foam as a carrier)
Industry: Consumable Medical Devices

Partnerships

Not specifically listed; collaborates with global distributors and OEM partners for product realization

Beyond the preview

Go deeper on Cenefom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cenefom.

Explore the full profile